GlassScriptPhysician profile
J Tyler Enders
NPI 1376920942
$20,681.61
in general payments reported to CMS, 2019-2025
34 companies · $2,922 in 2025
The $2,922 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $151 · 2021: $12K · 2022: $2,410 · 2023: $1,428 · 2024: $1,531 · 2025: $2,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,150 · Travel and Lodging: $1,463 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,149.92 |
| Travel and Lodging | $1,462.68 |
| Education | $268.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,871.74 | 2021-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Iconix |
| Pinnacle, INC | $4,842.38 | 2021 | |
| Arthrex, INC. | $3,560.76 | 2021 | |
| Impactortho, INC. | $2,941.40 | 2021-2024 | |
| Zimmer Biomet Holdings, INC. | $2,318.98 | 2021-2025 | Comprehensive Shoulder System, Maxbraid |
| Smith+Nephew, INC. | $357.73 | 2020-2024 | Trigen Intertan, Evos, Smart Tsf |
| Depuy Synthes Sales INC. | $306.86 | 2021-2025 | Na, Tfn-Advance, Va-Lcp |
| Djo, LLC | $155.20 | 2023-2025 | Cmf |
| Alafair Biosciences, INC. | $153.64 | 2024 | Versawrap |
| Davol INC. | $144.70 | 2021-2024 | |
| Abbvie INC. | $123.50 | 2023-2024 | |
| Vericel Corporation | $107.13 | 2022 | |
| Electronic Waveform Lab, INC. | $86.00 | 2024-2025 | |
| Arteriocyte Medical Systems, INC. | $79.49 | 2021 | |
| Ferring Pharmaceuticals INC. | $74.07 | 2021-2023 | Euflexxa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $67.91 | 2025 | Integrity Implant, Tactoset |
| Globus Medical, INC. | $61.73 | 2022-2023 | Evo Antegrade |
| Ethicon US, LLC | $54.92 | 2022 | |
| Paratek Pharmaceuticals, INC. | $44.96 | 2024 | Nuzyra |
| Orthofix Medical, INC. | $41.50 | 2024-2025 | Physio-Stim, Accelstim |
| Nalu Medical, INC. | $35.83 | 2022 | |
| Embody, INC. | $31.19 | 2022 | |
| Bioventus LLC | $30.18 | 2025 | Durolane |
| Integra Lifesciences Corporation | $24.62 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pacira Pharmaceuticals Incorporated | $23.53 | 2023 | Zilretta, Iovera |
| Fidia Pharma USA INC. | $23.17 | 2022 | |
| Avanos Medical | $21.33 | 2023 | Pnb and Accessories |
| Innovation Technologies INC | $17.19 | 2024 | Irrisept |
| Skeletal Dynamics INC | $15.66 | 2025 | Ijs, Geminus, Align |
| Sanofi-Aventis U.S. LLC | $14.19 | 2023 | |
| Mimedx Group, INC. | $13.93 | 2024 | |
| Theragen, INC. | $13.71 | 2023 | Kneehab Xp |
| Nevro Corp. | $12.22 | 2022 | |
| Illuminoss Medical, INC. | $10.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Enders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.